Skip to content
Login
Chamber Of Pharmaceutical Industry Cosmetics And Medical Supplies
Members News

The Board of Directors of the Pharmaceutical Industry Chamber at the Federation of Egyptian Industries held a meeting chaired by Dr. Gamal El-Leithy, during which the Board discussed several key issues and decisions concerning the pharmaceutical indu

The Board of Directors of the Pharmaceutical Industry Chamber at the Federation of Egyptian Industries held a meeting chaired by Dr. Gamal El-Leithy, during which the Board discussed several key issues and decisions concerning the pharmaceutical indu
Members News November 10, 2026

The meeting addressed several decisions issued by the Egyptian Drug Authority (EDA), particularly those governing the appointment of the Qualified Person (QP) within pharmaceutical manufacturing facilities. Discussions focused on the responsibilities and authorities assigned to the QP, ensuring that the role achieves its intended objectives and contributes to faster and more efficient procedures within factories, while maintaining full compliance with quality requirements and Good Manufacturing Practices (GMP).
The Board also discussed the Egyptian Drug Authority's decision issued on April 2, including its implementation requirements and deadlines. In addition, the Board reviewed the current position of pharmaceutical companies and their ability to meet these requirements within the specified timeframes.
The Board of Directors reaffirmed its full support for all initiatives aimed at enhancing the quality of the Egyptian pharmaceutical industry and developing it in accordance with international standards. It also emphasized the importance of ensuring that implementation mechanisms and timelines take into account practical realities and the capacity of companies to comply with the new requirements.
In this regard, it was decided to coordinate a meeting with the Chairman of the Egyptian Drug Authority to present the Pharmaceutical Industry Chamber's perspective and discuss the possibility of reconsidering certain implementation deadlines and extending them where necessary. This would provide companies with sufficient time to fulfill the Authority's requirements without compromising quality standards or the safety and efficacy of medicines.
We consistently emphasize that ongoing dialogue and coordination between the Egyptian Drug Authority and the Pharmaceutical Industry Chamber represent the most effective approach to achieving a balance between advancing the regulatory framework and supporting the national pharmaceutical industry. This, in turn, strengthens the ability of Egyptian medicines to meet patients' needs and compete in international markets.

Related News